These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 308122)

  • 1. Changes in T cell population in patients with bronchogenic carcinoma.
    Shirakusa T; Shigematsu N; Yoshida T; Saito R; Katayama N; Inokuchi K
    J Thorac Cardiovasc Surg; 1978 Aug; 76(2):262-5. PubMed ID: 308122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue polypeptide antigen in bronchogenic carcinoma.
    Zatloukal P; Glagolicová A; Linhart M; Sebes A; Hencl P; Mĕricka O
    Neoplasma; 1993; 40(5):301-3. PubMed ID: 8272159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral blood lymphocytes and their subpopulations in lung carcinoma.
    Zółtowska A; Skokowski J; Mlekodaj S; Boj E
    Arch Immunol Ther Exp (Warsz); 1980; 28(4):649-53. PubMed ID: 6970027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of histologic type and smoking status on interpretation of serum carcinoembryonic antigen value in non-small cell lung carcinoma.
    Okada M; Nishio W; Sakamoto T; Uchino K; Yuki T; Nakagawa A; Tsubota N
    Ann Thorac Surg; 2004 Sep; 78(3):1004-9; discussion 1009-10. PubMed ID: 15337038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Correlation between immuno-morphological parameters of regional lymph nodes and the mortality of patients with stage I and II bronchial squamos cell carcinoma].
    Kaufmann M; Wirth K; Scheurer J; Zimmermann A; Luscieti P; Stjernswärd J
    Helv Chir Acta; 1977 Oct; 44(4):549-54. PubMed ID: 617190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Results of resection treatment of locally limited bronchial carcinoma (Stages I and II)].
    Schamaun M; Angermeier J
    Schweiz Med Wochenschr; 1988 Oct; 118(39):1406-11. PubMed ID: 3051342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Status of detecting bronchial cancer in the Newbrandenburg district].
    Krecklow B; Krecklow K
    Z Erkr Atmungsorgane; 1986; 166(1):69-75. PubMed ID: 3006367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bronchogenic carcinoma in patients age 30 and younger.
    Whooley BP; Urschel JD; Antkowiak JG; Takita H
    Ann Thorac Cardiovasc Surg; 2000 Apr; 6(2):86-8. PubMed ID: 10870000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Results of the surgical treatment of locally-advanced bronchus carcinoma (stage III)].
    Schamaun M
    Schweiz Med Wochenschr; 1987 Sep; 117(39):1498-505. PubMed ID: 2823378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predominant infiltration of macrophages and CD8(+) T Cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer.
    Kawai O; Ishii G; Kubota K; Murata Y; Naito Y; Mizuno T; Aokage K; Saijo N; Nishiwaki Y; Gemma A; Kudoh S; Ochiai A
    Cancer; 2008 Sep; 113(6):1387-95. PubMed ID: 18671239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effect of sera of breast cancer patients on NK cell activity].
    Konjević G; Spuzić I
    Srp Arh Celok Lek; 1995; 123(9-10):227-31. PubMed ID: 17974436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Lymphocytes subpopulation in cancer's patients. Relationship with primitive anatomical location, histological type and clinical stage (author's transl)].
    Saiz Garcia F; Rodriguez Valverde V
    Bull Cancer; 1981; 68(1):32-9. PubMed ID: 6971668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bronchial carcinoma in subjects under 40].
    Ardissone F; Rapellino M; Obert R; Baldi S; Scappaticci E; Pecchio F; Borasio P
    Minerva Med; 1989 Dec; 80(12):1301-4. PubMed ID: 2560151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on angiogenesis intensity in lung cancer in aspect of its correlation with histological type of tumor and clinical stage.
    Juczewska M; Chyczewski L; Telego M; Chyczewska E; Nikliński J; Tańska M; Laudański J
    Rocz Akad Med Bialymst; 1997; 42 Suppl 1():254-70. PubMed ID: 9337543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sedimentation rate, leucocytes, platelet count and haemoglobin in bronchial carcinoma: an epidemiological study.
    Gislason T; Nõu E
    Eur J Respir Dis; 1985 Feb; 66(2):141-6. PubMed ID: 2982631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrinolysis in human bronchogenic carcinoma.
    Peterson HI; Larsson S; Zettergren L
    Bibl Anat; 1975; 13():315-6. PubMed ID: 182114
    [No Abstract]   [Full Text] [Related]  

  • 17. T-lymphocyte subsets in primary lung cancer.
    Tsuyuguchi I; Shiratsuchi H; Fukuoka M
    Jpn J Clin Oncol; 1987 Mar; 17(1):13-7. PubMed ID: 3494139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical usefulness of a new tumor marker CYFRA21-1 in patients with lung cancer].
    Li R; Li R; Wang Y
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 Jan; 21(1):26-9. PubMed ID: 11263296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognosis and survival in resected lung carcinoma based on the new international staging system.
    Naruke T; Goya T; Tsuchiya R; Suemasu K
    J Thorac Cardiovasc Surg; 1988 Sep; 96(3):440-7. PubMed ID: 2842549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Postoperative recurrence of the patients with the stage I, II non small cell lung cancer].
    Iwamoto I; Shibata K; Yoshioka M; Matsuzaki Y; Yamamoto T; Edagawa M; Kubota I; Tsuneyoshi A; Koga Y
    Kyobu Geka; 1990 Apr; 43(4):267-70. PubMed ID: 2161967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.